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Abstract
Orexin-A is a neuropeptide which has been suggested to be involved in sleep and arousal mechanisms. Orexin-A, for example,
stimulates arousal when administrated intracerebroventricularly to rats. We attempted to identify speciﬁc neural sites of orexin-A
and orexin-B action. Orexin-A and orexin-B were microinjected into the medial parvocellular subdivision of the paraventricular
nucleus (PVN) in anesthetized, spontaneously breathing rats, and cortical arousal and yawning responses were assessed. Cortical
arousal responses were monitored with the electrocorticogram (ECoG), and yawning responses were evaluated by monitoring
intercostal electromyograms as an index of inspiratory activity and digastric electromyograms as an indicator of mouth opening.
We also measured blood pressure and heart rate during yawning responses, since yawning is accompanied by changes in
autonomic activity. Microinjection of orexin-A into the PVN elicited an arousal shift in the ECoG to lower voltage and faster
rhythms. This cortical arousal response was followed by a single large inspiration with mouth opening, i.e. a yawning response.
On the other hand, microinjection of orexin-B into the PVN elicited an arousal shift in the ECoG without yawning responses.
These results demonstrate that an orexin receptive site for triggering arousal/yawning responses exists in the PVN, and suggest
that the PVN is involved in arousal mechanisms. © 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
We recently reported that a stereotyped yawning
response can be evoked by microinjection of L-gluta-
mate, cyanide and a nitric oxide-releasing compound
(NOC12) into the medial parvocellular subdivision of
the paraventricular nucleus (PVN) in anesthetized,
spontaneously breathing rats [13,23]. In those studies,
we recorded the electrocorticogram (ECoG) to evaluate
arousal responses during yawning, and found that
ECoG arousal, represented by lower voltage and faster
rhythms, occurred before the ﬁnal yawning behavior
during both spontaneous yawning and yawning re-
sponses evoked by chemical stimulation. This arousal
effect was of considerable signiﬁcance because the data
were obtained under anesthesia. Although the PVN is
essential for the occurrence of yawning [1], our previous
studies raised the possibility that the PVN may play an
important role in triggering arousal mechanisms. We
therefore suggested that the yawning model is appropri-
ate for investigating arousal mechanisms in rats.
Orexins (A and B) are a recently identiﬁed family of
neuropeptides originally believed to be important medi-
ators of food intake [22]. Apart from appetite regula-
tion, orexins have now emerged as important regulators
of sleep and arousal [3,8,21,25]. For example, Chernelli
et al. [3] proposed that orexin knockout mice may be a
model for human narcolepsy. They further observed
that orexin neurons innervate neurons critical for con-
trolling arousal in the ascending cortical activation
system. Hagan et al. [8] demonstrated that orexin-A
activates locus coeruleus cell ﬁring in vitro and in-
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creases arousal in rats in vivo. Moreover, Piper et al.
[21] reported that orexin-A modiﬁes the sleep–wake
cycle of rats. In those studies, orexin-A stimulated
arousal after intracerebroventricular injection, but the
precise site of action within the brain for orexin-A to
stimulate arousal remains unknown.
We sought to determine whether the PVN is orexin
sensitive by microinjecting orexin-A into the speciﬁc
region within the PVN where a stereotyped yawning
response was induced by L-glutamate. The effect of
orexin-B microinjection into the PVN was also exam-
ined. The doses of orexin-A and orexin-B used in the
present study were at least 1000 times smaller than
those used for feeding responses in microinjection stud-
ies of the PVN [7,26]. All microinjections were done
with multi-barrel glass micropipettes which provide es-
pecially high resolution, thus stimulating only a re-
stricted region within the PVN.
2. Materials and methods
Experiments were performed on 12 male Wistar rats
weighing 300–450 g. The rats were anesthetized with 50
mg/kg pentobarbital sodium intraperitoneally, and ad-
ditional doses were given as needed. All experiments
were approved by the Animal Experimentation Ethics
Committee of the Toho University School of Medicine.
All efforts were made to minimize animal suffering and
the number of animals used. Surgical procedures were
essentially the same as described previously [23]. In
brief, catheters were placed in the femoral artery to
monitor arterial blood pressure (BP). Heart rate (HR)
was measured from the BP pulse with a tachometer
(AT-601G, Nihon Kohden, Japan). To monitor respira-
tory activity, a pair of twisted wire electrodes, insulated
except for 1 mm at the tips, were implanted into the
lower intercostal space, by way of a 23-gage hypoder-
Fig. 1. Representative yawning responses to injection of L-glutamate (5 nmol) in the PVN (A). Changes in the ECoG recording before (B), during
(C) and after (C) yawning are shown in the lower panel. During the control period before chemical stimulation, the ECoG of anesthetized rats
was characterized by very slow waves (2 Hz). Note that the waves shifted to lower amplitude faster rhythms (indicated by arrows) after
microinjection of L-glutamate into the PVN. BP, blood pressure; HR, heart rate; EMGIC, intercostal electromyogram; EMGJAW, digastric
electromyogram; ECoG, cortical electroencephalograph.I. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 171
Fig. 2. Representative yawning/arousal responses evoked by microinjection of orexin-A (0.3 pmol) into the PVN. Note that the ECoG waves
shifted to lower voltages after microinjection of orexin-A into the PVN. Abbreviations as in Fig. 1.
mic needle; the needle was then withdrawn, leaving the
wires in the intercostal muscle. Similarly, pairs of wire
electrodes were implanted in the digastric muscle to
monitor mouth opening activity. For ECoG recordings,
holes were drilled in the skull and two screw electrodes
were implanted. ECoG signals were ampliﬁed and
ﬁltered (0.1–50.0 Hz bandpass). These polygraphic sig-
nals were all stored in a DAT data recorder (PC208Ax,
Sony, Japan) for further analysis. Rectal temperature
was maintained at 37°C with a heating lamp.
The animals were ﬁxed prone in a stereotaxic frame
and a parietal craniotomy was performed. For drug
microinjections into the PVN of the hypothalamus, we
constructed a four-barrel glass micropipette which was
connected to a ﬁne cannula. The free end of the can-
nula was attached to a picopump (PV830 Pneumatic,
WPI) for injections. The volumes injected were moni-
tored under a dissecting microscope and measured from
the movement of the ﬂuid meniscus. The barrels were
ﬁlled with either 0.1 M L-glutamate, 10–100 g/ml
orexin-A (Phoenix Pharmaceuticals, INC), 10–100 g/
ml orexin-B (Phoenix Pharmaceuticals, INC), or artiﬁ-
cial cerebrospinal ﬂuid (ACSF: 147 mM NaCl, 3 mM
NaHCO3, 3.5 mM KCl, 1.3 mM CaCl2, 1.1 mM
MgCl2, 0.5 mM NaH2PO4 and 1.1 mM urea; pH 7.30–
7.35). L-Glutamate, orexin-A and orexin-B were freshly
dissolved in ACSF, respectively. As a control for L-glu-
tamate, orexin-A and orexin-B, the same amount of
ACSF was injected in responsive sites (three rats). The
chemicals were obtained from Wako, Japan. The dura
overlying the cortex was opened for advancement of the
micropipette, which was inserted into an area 0.2–0.3
mm lateral to the midline and 1.1–2.4 mm posterior to
the bregma, 5.8–7.2 mm vertical from the parietal dura,
according to the Paxinos and Watson [20] atlas of the
rat brain. We made a systematic search for the sites
from which yawning responses were evoked by microin-
jection of L-glutamate (10–100 nl). After exploratory
tracking with L-glutamate, we identiﬁed sites where
maximal yawning responses were obtained. A small
volume (10–100 nl) of either orexin-A or orexin-B
solution was then slowly injected into the same respon-
sive site to evaluate whether a yawning response could
be induced. On completion of the experiment, success-
ful stimulation sites were marked by 0.5 M acetate-pon-
tamine for histological examination. The rat was then
deeply anesthetized with pentobarbital sodium (100 mg/
kg) to remove the brain.
After the experiments, ECoG signals were displayed
on an oscilloscope, together with intercostal EMG. For
power spectrum analysis, the ECoG signal was digitized
at a sampling rate of 1024 Hz and subjected to fast
Fourier transforms. Analyses were performed on data
sampled during pre-injection (control), early yawningI. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 172
and late yawning (recovery) periods of each response.
The early yawning period was selected on the basis of
visual inspection as the early phase of a yawning re-
sponse, corresponding to an initial depressor response
prior to a ﬁnal yawning event (a single large inspira-
tion). The late yawning (recovery) period was 15–120 s
until ECoG activity returned to pre-injection activity
levels. In the case of orexin-B, analyses were performed
on data sampled during pre-injection (control), and
post-injection of each response.
Statistical analyses were carried out by one-way anal-
ysis of variance, followed by Sheffe’s test to correct for
multiple comparisons of treatments. A probability
value of 0.05 was adopted as the level of signiﬁcance.
3. Results
We ﬁrst made a systematic search for yawning-re-
sponsive sites in and around the PVN by microinjection
of L-glutamate. Microinjection of L-glutamate in the
medial parvocellular subdivision of the PVN elicited a
stereotyped yawning response. We conﬁrmed that no
other sites in and around the PVN could elicit this
stereotyped response. A typical example of such a
stereotyped yawning response induced by L-glutamate
(5 nmol) is shown in Fig. 1A. The response pattern was
characterized by an initial depressor phase followed by
a ﬁnal yawning event (a single large inspiratory effort).
Power spectral analysis of ECoG waves is shown in the
lower panel. During the control period before chemical
stimulation, the ECoG of anesthetized rats was charac-
terized by high voltage and very slow waves (2H z ,
Fig. 1B). Concurrent with the depressor response,
ECoG waves shifted to lower voltage and faster
rhythms (4 Hz, Fig. 1C). The component of faster
rhythms remained after the ﬁnal yawning behavior
(Fig. 1D), and returned gradually to control levels.
These results were comparable to those of our previous
studies [13,23].
We next examined the effect of microinjection of
orexin-A in the speciﬁc region with the stereotyped
yawning. Fig. 2 shows a typical example of the effect of
orexin-A injection into the site where the stereotyped
yawning response was elicited by L-glutamate injection.
Orexin-A injection (0.3 pmol) qualitatively caused simi-
lar sequential events of a stereotyped yawning response.
The initial response represented an increase in HR and
Fig. 3. Typical changes in the cortical electroencephalograph recording during yawning induced after microinjection of orexin-A (0.3 pmol) into
the PVN. The very slow waves (2 Hz) during the control period before chemical stimulation were replaced by faster rhythms (6H z )
immediately before yawning. Abbreviations as in Fig. 1.I. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 173
Fig. 4. Representative response evoked by microinjection of orexin-B (0.3 pmol) into the PVN. No yawning responses emerged after microinjection
of orexin-B into the PVN. Abbreviations as in Fig. 1.
an arousal shift in the ECoG to lower voltage, as
described precisely in the next paragraph. EMGJAW
showed quite rhythmical activity. These early yawning
responses were followed by the development of a single
large inspiration. After the ﬁnal yawning behavior, BP
and HR returned gradually to control levels. As for
ECoG, the component of lower voltage remained after
the ﬁnal yawning behavior, but this also returned grad-
ually to control levels.
Power spectral analysis of ECoG waves revealed that
an early change in ECoG occurred prior to a yawn, as
shown in Fig. 3. The high voltage and very slow waves
during the control period before chemical stimulation
(2 Hz, Fig. 3: Control), were replaced by faster
rhythms concurrent with the cardiovascular and
EMGJAW responses (6 Hz, Fig. 3: Early). The com-
ponent of faster rhythms remained after the ﬁnal yawn-
ing behavior (Fig. 3: Late-1, Late-2, Late-3), and
returned gradually to control levels (Fig. 3: Late-4). We
examined the effects of orexin-A injection in 12 sites
(one site per rat) and found that orexin-A injection
caused the yawning/arousal response in all sites
examined.
We further evaluated the effect of orexin-B injection
in the speciﬁc regions where the stereotyped yawning
responses were elicited by both L-glutamate and orexin-
A injections, as shown a typical example in Fig. 4. In
contrast to results obtained by orexin-A, no major
effects of orexin-B were observed at any dose; orexin-B
(0.3 pmol) did not induce the yawning response, the
increase in HR was weak or negligible, and EMGJAW
showed a little activity. However, power spectral analy-
sis of ECoG waves revealed that a change in ECoG
occurred after administration, as shown in Fig. 5. Dur-
ing the control period before chemical stimulation, the
ECoG of anesthetized rats was characterized by high
voltage and very slow waves (2 Hz, Fig. 5: Control).
ECoG waves shifted to faster rhythms (6 Hz) after
the injection (Fig. 5: Post-1). This arousal shift in
ECoG reached as maximum 30–60 s after the injection
(Fig. 5: Post-2). The component of faster rhythms
remained for another 150 s (Fig. 5: Post-3, Post-4,
Post-5), and returned gradually to control levels (Fig. 5:
Post-6). Similar arousal responses to orexin-B injection
were obtained from all sites examined (ﬁve sites from
ﬁve rats).
Light microscopic examination revealed that both
orexin-A and orexin-B responsive sites were located in
the medial part of the rostral PVN. No responsive sites
for yawning/arousal response were identiﬁed in the
lateral part of the rostral PVN, in the caudal PVN, or
regions around the PVN.
4. Discussion
This is the ﬁrst study showing effects of microinject-
ing orexin-A and orexin-B into the PVN on arousalI. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 174
parameters recorded in anesthetized rats. Microinjec-
tion of orexin-A into the PVN induced yawning, to-
gether with an arousal shift in the ECoG. On the other
hand, orexin-B induced an arousal shift in the ECoG
without a yawning response. These ﬁndings suggest that
the PVN is an orexin-sensitive site, and that this site
might be involved in an arousal signaling pathway.
Our observation that the PVN is an orexin-sensitive
site is supported by several lines of evidence. Trivedi et
al. [27] reported that orexin receptors are found in the
PVN, and Date et al. [5] provided other evidence
showing that orexin ﬁbers are extensively found at that
site. Further evidence comes from Dube et al.’s [7]
observation that orexin-A enhances food intake when
injected into the PVN. These data together raise the
possibility that the PVN may be one of the important
targets receiving orexinergic inputs from the posterior
and lateral hypothalamus.
The receptor expressed in the PVN might be the
orexin receptor 2 (OX2R). Two receptor types have
been identiﬁed for orexin-A and orexin-B: orexin recep-
tor 1 (OX1R) and OX2R [27]. Whereas OX2R binds
both orexin-A and orexin-B at high afﬁnity, OX1R
binds orexin-A preferentially over orexin-B [12]. Our
data showing that both orexin-A and orexin-B induced
arousal shifts in the ECoG suggest that this effect is
mediated by OX2R. The suggestion is supported by
data of Trivedi et al. [27] who found that OX2Ri s
predominantly found in the PVN. However, the lack of
orexin-B to induce either yawning or cardiovascular
responses raises another possibility that the respiratory
and cardiovascular effects induced by orexin-A might
be OX1R mediated.
Neurons responsible for the effects induced by either
orexin-A or orexin-B might be the parvocellular neu-
rons of the PVN. This suggestion was based on our
earlier ﬁnding showing that the parvocellular division in
the PVN is essential for the stereotyped yawning re-
sponse, involving the arousal shift in the ECoG [13].
This is consistent with the observation of Date et al. [5]
who found that orexin ﬁbers project to the parvocellu-
lar division of the PVN. In this connection, intercere-
broventricular administration of orexin-A induced c-fos
mRNA in the parvocellular division of the PVN [15].
Consistently, corticotropin-releasing factor, which is
mainly synthesized by the parvocellular neurons in the
PVN, is increased by intercerebroventricular adminis-
tration of orexin-A [8,11,27].
We previously reported that neurons responsible for
yawning might be the oxytocinergic parvocellular neu-
Fig. 5. Typical changes in the cortical electroencephalograph recording during yawning induced after microinjection of orexin-B (0.3 pmol) into
the PVN. During the control period before chemical stimulation, the ECoG of anesthetized rats was characterized by very slow waves (2 Hz).
The waves shifted to faster rhythms (6 Hz) after microinjection of orexin-B into the PVN. Abbreviations as in Fig. 1.I. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 175
Fig. 6. Schematic representation of our model on yawning/arousal responses mediated through the PVN. Orexin neurons from the LHA may
directly activate neurons in the PVN, which in turn project to the LC or the basal forebrain. Oxytocinergic neurons from the PVN project to the
lower brainstem, including the facial nucleus and respiratory related neurons which are implicated in the yawning response. OXT, oxytocin; OX,
orexin; NA, noradrenaline; Ach, acetylcholine.
rons in the PVN projecting to the lower brain stem [23].
Our suggestion was principally based on the report of
Sawchenko and Swanson [24] who demonstrated that
oxytocinergic parvocellular neurons in the PVN send
descending axons to the lower brain stem, a region
involved in arousal, respiratory, cardiovascular, and
other autonomic functions. We therefore further sug-
gest the possibility that at least orexin-A activates the
oxytocinergic parvocellular neurons in the PVN pro-
jecting to the lower brain stem. This possibility should
be investigated further through the use of immunohis-
tochemical techniques.
Recent studies show that dense arborization of
orexin axons is detected in the locus coeruleus (LC), a
region involved in arousal mechanisms [10]. Orexin
axons also innervate cholinergic neurons of the basal
forebrain [12], i.e. another region implicated in sleep/
arousal regulation [17]. The source of orexin neurons in
either LC or the basal forebrain is suggested to be the
lateral hypothalamic area (LHA) [10,12]. Although
orexin neurons in either LC or the basal forebrain may
directly extend from the LHA, our present data suggest
another signaling pathway of the arousal mechanism
via the PVN. Namely, orexin neurons from the LHA
may directly activate parvocellular neurons in the PVN,
which in turn project to the LC or the basal forebrain
(Fig. 6).
Much of the focus on orexin peptides has been
related to the ability of orexin-A to stimulate food
intake or arousal responses when intracerebroventricu-
larly administrated [7,8,21,26]. However, the effect of
orexin-B has been problematic in most studies. The
present ﬁndings that orexin-B preferentially stimulated
the arousal shift in the ECoG led us to propose that
this substance may have a role in arousal regulation,
whereas orexin-A may function in various autonomic
responses, including the arousal response. This view is
consistent with the data of Horvath et al. [10] who
reported that orexin-B enhances activity of the LC
noradrenergic system which is important in arousal
regulation. The difference in function of orexin-A and
orexin-B is at this time unknown, and remains to be
clearly demonstrated.
It may be argued that injections of orexins into the
PVN were large, and could have diffused into the LHA,
which has many of the same projections as the PVN,
and could account for current ﬁndings. This possibility
is not likely, because all microinjections were performed
with glass micropipettes in the present study, thus
restricting stimulation to portions within the PVN.
Histological examination revealed that injections dif-
fused only within the medial parvocellular subdivision
of the PVN. We also conﬁrmed that no other area in
and around the PVN elicited the arousal/yawning re-I. Sato-Suzuki et al. / Behaioural Brain Research 128 (2002) 169–177 176
sponse. As determined by onset latencies of arousal/
yawning responses, neurons in the PVN responded to
orexins within 30 s and returned to near baseline levels
within 3 min, whereas the feeding [7,26], drinking [14]
or arousal responses [21] in other studies occurred ﬁrst
after 1 or 2 h, and the effects lasted more than several
hours.
The yawning response has important physiological
signiﬁcance for arousal in anesthetized animals. It is
apparent from observing human subjects that yawning
is not a behavior restricted to mouth opening, but is a
coordinated motor pattern characterized by a deep
inspiration and stretching of the trunk [2]. Yawning is
also accompanied by changes in autonomic function,
including a depressor response [23], lacrimation and
erection [9,18]. Furthermore, yawning is a phenomenon
that subserves arousal [4]. To evaluate these various
physiological aspects of yawning, we monitored poly-
graphic measures representing a yawning response in
anesthetized, spontaneously breathing rats. It is impor-
tant to emphasize that if we used conscious animals, the
data obtained would be almost certainly restricted to
counting the number of mouth openings, which shows
only one aspect of the entire yawning response.
Whereas the ECoG of anesthetized rats is normally
characterized by high voltage and very slow waves (2
Hz), faster rhythms (4–6 Hz) became dominant after
chemical stimulation of the PVN. Since this arousal
shift in the ECoG was usually accompanied by yawning
responses, we suggest that the PVN mediates the corti-
cal activation related to yawning. In this respect, Drin-
genberg and Vanderwolf [6] demonstrated that several
pathways contribute to ECoG activation as well as
arousal mechanisms. Our ﬁndings indicate that the
PVN plays a signiﬁcant role in the arousal mechanism
related to yawning.
Narcolepsy, a disorder characterized by excessive
daytime sleepiness, cataplexy, and striking transitions
from wakefulness into rapid eye movement sleep, is
apparently caused by orexin and orexin receptor deﬁ-
ciency in human [19] and animal models [3,16]. The
type of orexin receptor deﬁciency in this disorder is
OX2R, which is predominantly found in the PVN [16].
These data together suggest orexin as a major neuro-
transmitter involved in sleep and arousal mechanisms,
and further strengthen our hypothesis that the PVN
plays an important role in arousal systems.
In conclusion, microinjection of orexin-A into the
PVN elicited an arousal/yawning response, whereas
orexin-B injection induced the arousal response alone.
The results demonstrate that an orexin receptive site for
triggering arousal/yawning responses exists in the PVN.
Our ﬁnding should open a new avenue of research to
investigate the role of the PVN in arousal regulation.
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